首页> 外文会议> >RELATING INTRA-TUMOR HETEROGENEITY TO MORPHOLOGY AND ITS IMPLICATIONS FOR ASSESSING RESPONSE TO THERAPY
【24h】

RELATING INTRA-TUMOR HETEROGENEITY TO MORPHOLOGY AND ITS IMPLICATIONS FOR ASSESSING RESPONSE TO THERAPY

机译:肿瘤内异质性与形态学的关系及其对治疗反应的评估意义

获取原文
获取外文期刊封面目录资料

摘要

Tumor heterogeneity has major implications for tumor development and response to therapy. We relate intra-tumor heterogeneity to morphology as determined by MRI (or CT) images by applying a biologically-inspired model of tumor growth. This model represents the development of a tumor as a set of expanding spheres, each representing a distinct clonal center, with the sprouting of new spheres representing new centers. Each clonal center may possess different characteristics, including genetic composition, growth rate and response to treatment. A major implication of our work is that assessment of a tumor using volume measurements (RECIST, WHO) may not accurately reflect the response to treatment. The application of this new concept to clinical imaging studies has confirmed its ability to track and inform clinicians more accurately about changes in tumor size and morphology due to growth or therapeutic intervention.
机译:肿瘤异质性对肿瘤的发展和对治疗的反应具有重要意义。通过应用生物学启发的肿瘤生长模型,我们将肿瘤内异质性与MRI(或CT)图像确定的形态相关联。该模型将肿瘤发展为一组扩展的球体,每个球体代表一个独特的克隆中心,而新球体的萌芽则​​代表了新的中心。每个克隆中心可能具有不同的特征,包括遗传组成,生长速率和对治疗的反应。我们工作的主要含义是使用体积测量(RECIST,WHO)评估肿瘤可能无法准确反映对治疗的反应。该新概念在临床影像学研究中的应用已证实其具有能力,能够更准确地跟踪和告知临床医生由于生长或治疗干预引起的肿瘤大小和形态变化。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号